Specific antibiotics in the treatment of periodontitis - A proposed strategy

Journal of Periodontology

Volumn 75, Issue 1, 2004, Pages 169-175

  Beikler, Thomas ^a   Prior, Karola ^a   Ehmke, Benjamin ^a   Flemmig, Thomas F ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antibiotics, antibacterial therapeutic use; Antibiotics, combination therapeutic use; Periodontal diseases epidemiology; Periodontal diseases microbiology; Periodontal diseases therapy; Polymerase chain reaction

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; METRONIDAZOLE; TETRACYCLINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; DRUG SPECIFICITY; EIKENELLA CORRODENS; FEMALE; GINGIVITIS; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PERIODONTITIS; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PREVALENCE; PREVOTELLA INTERMEDIA; PREVOTELLA NIGRESCENS; TOOTH PLAQUE;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL TYPING TECHNIQUES; BIOFILMS; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERIODONTITIS;

EID: 1542360536     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.1.169     Document Type: Article

References (56)

1. Tran SD, Rudney JD, Sparks BS, Hodges JS. Persistent presence of Bacteroides forsythus as a risk factor for attachment loss in a population with low prevalence and severity of adult periodontitis. J Periodontol 2001;72:1-10.
2. Umeda M, Chen C, Bakker I, Contreras A, Morrison JL, Slots J. Risk indicators for harboring periodontal pathogens. J Periodontol 1998;69:1111-1118.
3. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11:266-273.
4. Slots J, Ashimoto A, Flynn MJ, Li G, Chen C. Detection of putative periodontal pathogens in subgingival specimens by 16S ribosomal DNA amplification with the polymerase chain reaction. Clin Infect Dis 1995;20 (Suppl. 2):S304-S307.
5. Tanner A, Maiden MF, Macuch PJ, Murray LL, Kent RL Jr. Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol 1998;25:85-98.
6. Ximenez-Fyvie LA, Haffajee AD, Socransky SS. Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis. J Clin Periodontol 2000;27: 722-732.
7. Ximenez-Fyvie LA, Haffajee AD, Socransky SS. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J Clin Periodontol 2000;27:648-657.
8. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
9. Socransky SS, Smith C, Haffajee AD. Subgingival microbial profiles in refractory periodontal disease. J Clin Periodontol 2002;29:260-268.
10. Edwardsson S, Bing M, Axtelius B, Lindberg B, Soderfeldt B, Attstrom R. The microbiota of periodontal pockets with different depths in therapy-resistant periodontitis. J Clin Periodontol 1999;26:143-152.
11. American Academy of Periodontology. Systemic antibiotics in periodontics (position paper). J Periodontol 1996; 67:831-838.
12. Slots J, Jorgensen MG. Effective, safe, practical and affordable periodontal antimicrobial therapy: Where are we going, and are we there yet? Periodontol 2000 2002; 28:298-312.
13. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
14. Tonjum T, Haas R. Identification of Actinobacillus actinomycetemcomitans by leukotoxin gene-specific hybridization and polymerase chain reaction assays. J Clin Microbiol 1993;31:1856-1859.
15. Bodinka A, Schmidt H, Henkel B, Flemmig TF, Klaiber B, Karch H. Polymerase chain reaction for the identification of Porphyromonas gingivalis collagenase genes. Oral Microbiol Immunol 1994;9:161-165.
16. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-238.
17. Kleinfelder JW, Muller RF, Lange DE. Antibiotic susceptibility of putative periodontal pathogens in advanced periodontitis patients. J Clin Periodontol 1999;26:347-351.
18. Walker CB, Gordon JM, Cornwall HA, Murphy JC, Socransky SS. Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria. Antimicrob Agents Chemother 1981;19:867-871.
19. Olsvik B, Tenover FC. Tetracycline resistance in periodontal pathogens. Clin Infect Dis 1993; 16(Suppl. 4): S310-S313.
20. Tenenbaum H, Jehl F, Gallion C, Dahan M. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol 1997;24:804-807.
21. Conway TB, Beck FM, Walters JD. Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites. J Periodontol 2000;71:1448-1452.
22. Baker PJ, Evans RT, Slots J, Genco RJ. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. J Dent Res 1985;64:1233-1244.
23. Eick S, Pfister W, Straube E. Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. Int J Antimicrob Agents 1999;12:41-46.
24. Madinier IM, Fosse TB, Hitzig C, Charbit Y, Hannoun LR. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J Periodontol 1999;70:888-892.
25. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans. Scand J Dent Res 1993;101:299-303.
26. Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol 1999;26:261-263.
27. Takemoto T, Kurihara H, Dahlen G. Characterization of Bacteroides forsythus isolates. J Clin Microbiol 1997;35: 1378-1381.
28. Andres MT, Chung WO, Roberts MC, Fierro JF. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 1998;42: 3022-3023.
29. Bernal LA, Guillot E, Paquet C, Mouton C. Beta-lactamase-producing strains in the species Prevotella intermedia and Prevotella nigrescens. Oral Microbiol Immunol 1998;13:36-40.
30. Haffajee AD, Cugini MA, Tanner A, et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol 1998;25:346-353.
31. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002;28:106-176.
32. Winkel EG, van Winkelhoff AJ, Barendregt DS, van der Weijden GA, Timmerman MF, van der Velden U. Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study. J Clin Periodontol 1999; 26:461-468.
33. Serino G, Rosling B, Ramberg P, Hellstrom MK, Socransky SS, Lindhe J. The effect of systemic antibiotics in the treatment of patients with recurrent periodontitis. J Clin Periodontol 2001;28:411-418.
34. Ramberg P, Rosling B, Serino G, Hellstrom MK, Socransky SS, Lindhe J. The long-term effect of systemic tetracycline used as an adjunct to non-surgical treatment of advanced periodontitis. J Clin Periodontol 2001;28:446-452.
35. Feres M, Haffajee AD, Goncalves C, et al. Systemic doxycycline administration in the treatment of periodontal infections (I). Effect on the subgingival microbiota. J Clin Periodontol 1999;26:775-783.
36. Palmer RM, Watts TL, Wilson RF. A double-blind trial of tetracycline in the management of early onset periodontitis. J Clin Periodontol 1996;23:670-674.
37. Saxen L, Asikainen S, Kanervo A, Kari K, Jousimies-Somer H. The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis. Arch Oral Biol 1990;35(Suppl.):227S-229S.
38. Asikainen S, Jousimies-Somer H, Kanervo A, Saxen L. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis. Arch Oral Biol 1990;35(Suppl.):231S-234S.
39. Kunihira DM, Caine FA, Palcanis KG, Best AM, Ranney RR. A clinical trial of phenoxymethyl penicillin for adjunctive treatment of juvenile periodontitis. J Periodontol 1985;56:352-358.
40. Flemmig TF, Milian E, Karch H, Klaiber B. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis. J Clin Periodontol 1998;25: 380-387.
41. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-1776.
42. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:711-745.
43. Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996;40:2517-2522.
44. Socransky SS, Haffajee AD. Dental biofilms: Difficult therapeutic targets. Periodontol 2000 2002;28:12-55.
45. Pitt WG, McBride MO, Lunceford JK, Roper RJ, Sagers RD. Ultrasonic enhancement of antibiotic action on Gram-negative bacteria. Antimicrob Agents Chemother 1994;38:2577-2582.
46. van Winkelhoff AJ, Herrera GD, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol 2000;27: 79-86.
47. Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183: 3770-3783.
48. Reynaud AH, Nygaard-Ostby B, Boygard GK, Eribe ER, Olsen I, Gjermo P. Yeasts in periodontal pockets. J Clin Periodontol 2001;28:860-864.
49. Contreras A, Slots J. Mammalian viruses in human periodontitis. Oral Microbiol Immunol 1996;11:381-386.
50. Contreras A, Slots J. Herpesviruses in human periodontal disease. J Periodont Res 2000;35:3-16.
51. Amsden GW, Duran JM. Interpretation of antibacterial susceptibility reports: In vitro versus clinical breakpoints. Drugs 2001;61:163-166.
52. Woodnutt G. Pharmacodynamics to combat resistance. J Antimicrob Chemother 2000;46(Suppl. T1):25-31.
53. Dudley MN, Ambrose PG. Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: Ready for prime time. Curr Opin Microbiol 2000;3:515-521.
54. Pavicic MJ, van Winkelhoff AJ, de Graaff J. Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1991;35:961-966.
55. Jousimies-Somer H, Asikainen S, Suomala P, Summanen P. Activity of metronidazole and its hydroxymetabolite against clinical isolates of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1988;3: 32-34.
56. Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid, and saliva. J Clin Periodontol 2000;27:53-60.